“…In some diseases, as SCA1 (MIM# 164400), SCA2 (MIM# 183090), fragile-X syndrome (MIM# 300624), myotonic dystrophy type 2 (DM2; MIM# 602668), and Friedrich ataxia (FRDA; MIM# 229300), nonpathogenic alleles are more likely to be interrupted than expanded alleles, whereas in SCA8 (MIM# 608768), SCA10 (MIM# 603516), and DM1 (MIM# 160900) interruptions are more expected in expanded alleles (Braida et al, 2010;Chung et al, 1993;Hu et al, 2017;Imbert et al, 1996;Landrian et al, 2017;Liquori et al, 2003;Maia et al, 2017;Martins et al, 2005;Menon et al, 2013;Montermini et al, 1997;Moseley et al, 2000;Musova et al, 2009;Ramos et al, 2010;Yrigollen et al, 2014;Zuhlke et al, 2002). Depending on the gene, interruptions in the repetitive tract may be randomly positioned, as in ATXN2, ATXN8OS, and ATXN10, or follow a pattern (Chung et al, 1993;Landrian et al, 2017;Yrigollen et al, 2014). In FMR1, AGG interruptions are usually located every nine or 10 CGGs, whereas in ATXN1 interrupted alleles have one to three CAT interruptions in the middle of the allele intercalated with one CAG, following a configuration from (CAG) n CAT (CAG) n to (CAG) n CAT CAG CAT CAG CAT (CAG) n (Chung et al, 1993;Yrigollen et al, 2014).…”